Analysen von James Quigley
| 05.06.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 16.05.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 16.04.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 11.03.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.03.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.02.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 09.01.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 14.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.10.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 17.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.09.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.01.23 | Merck Overweight | Morgan Stanley | |
| 29.04.22 | EVOTEC Overweight | Morgan Stanley | |
| 25.04.22 | Bayer Overweight | Morgan Stanley | |